Federation des caisses Desjardins du Quebec’s Acorda Therapeutics ACOR Stock Holding History

Federation des caisses Desjardins du Quebec’s Portfolio ACOR Stock Details ACOR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-264	Closed	-$29.9K	–	2297
2020 Q1	$29.9K	Hold	264	–	–	﹤0.01%	1400
2019 Q4	$64.6K	Hold	264	–	–	﹤0.01%	1447
2019 Q3	$91K	Hold	264	–	–	﹤0.01%	1328
2019 Q2	$242K	Buy	264 +68	+35%	+$83.6K	﹤0.01%	985
2019 Q1	$312K	Buy	196 +122	+165%	+$220K	﹤0.01%	845
2018 Q4	$138K	Buy	+74	New	+$161K	﹤0.01%	1063

Other funds holding ACOR

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Federation des caisses Desjardins du Quebec's ACOR Position: Q2 2020 in Review

Federation des caisses Desjardins du Quebec sold out of Acorda Therapeutics (ACOR) in Q2 2020, closing a stake of 264 shares — an estimated $29.9K sold.

Federation des caisses Desjardins du Quebec first reported a position in ACOR in Q4 2018 and held it in 6 quarters. The position peaked at $312K in Q1 2019. 79 funds tracked by Wall St. Rank hold ACOR as of Q2 2020.

Federation des caisses Desjardins du Quebec reported no remaining Acorda Therapeutics position as of Q2 2020 after selling out during the quarter.
Federation des caisses Desjardins du Quebec sold 264 Acorda Therapeutics shares in Q2 2020, an estimated $29.9K.
Federation des caisses Desjardins du Quebec first reported a position in Acorda Therapeutics in Q4 2018 and held it in 6 quarters.
Federation des caisses Desjardins du Quebec's Acorda Therapeutics position peaked at $312K in Q1 2019.
79 funds tracked by Wall St. Rank held Acorda Therapeutics as of Q2 2020.

Based on Federation des caisses Desjardins du Quebec's 13F filing for Q2 2020, filed 30 Aug 2024.